Walleye Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-61,745
Closed -$905K – 5439
2023
Q4
$905K Buy
61,745
+33,838
+121% +$472K ﹤0.01% 2440
2023
Q3
$402K Buy
27,907
+8,732
+46% +$136K ﹤0.01% 2979
2023
Q2
$315K Buy
+19,175
New +$313K ﹤0.01% 2758

Other funds holding BMEZ

Walleye Capital's BMEZ Position: Q1 2024 in Review

Walleye Capital sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 61,745 shares — an estimated $905K sold.

Walleye Capital first reported a position in BMEZ in Q2 2023 and held it in 3 quarters. The position peaked at $905K in Q4 2023. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Walleye Capital reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 61,745 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $905K.
  • Walleye Capital first reported a position in BlackRock Health Sciences Trust II in Q2 2023 and held it in 3 quarters.
  • Walleye Capital's BlackRock Health Sciences Trust II position peaked at $905K in Q4 2023.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.